Cell News and Research

RSS
Differences in effectiveness among antihyperglycemic drugs on dementia risk identified in recent study

Differences in effectiveness among antihyperglycemic drugs on dementia risk identified in recent study

Scale Biosciences announces ScalePlex technology to simplify single cell genomics studies of any scale

Scale Biosciences announces ScalePlex technology to simplify single cell genomics studies of any scale

Researchers uncover molecular signatures of blood-brain barrier dysfunction in Alzheimer's disease

Researchers uncover molecular signatures of blood-brain barrier dysfunction in Alzheimer's disease

Maternal cell phone use associated with decrease in infants' speech development

Maternal cell phone use associated with decrease in infants' speech development

Nonhuman primate model reveals early-stage Alzheimer’s disease progression

Nonhuman primate model reveals early-stage Alzheimer’s disease progression

“G900” gene enhancers may play a pivotal role in asthma-associated inflammation

“G900” gene enhancers may play a pivotal role in asthma-associated inflammation

Study provides resource for investigating diabetes-linked transcription factors

Study provides resource for investigating diabetes-linked transcription factors

Breakthrough biomarker predicts recurrence risk in clear cell renal cancer

Breakthrough biomarker predicts recurrence risk in clear cell renal cancer

Study reveals brain health benefits of intermittent fasting and healthy diet plans

Study reveals brain health benefits of intermittent fasting and healthy diet plans

New curative treatment for sickle cell disease shows promising results in international trial

New curative treatment for sickle cell disease shows promising results in international trial

Pentraxin 3 as a predictor of advanced fibrosis and carotid intima-media thickness in MAFLD patients

Pentraxin 3 as a predictor of advanced fibrosis and carotid intima-media thickness in MAFLD patients

Combining CYFRA 21-1 with CXCR1 and cxcr2 levels for predicting recurrence in stage III squamous cell lung carcinoma

Combining CYFRA 21-1 with CXCR1 and cxcr2 levels for predicting recurrence in stage III squamous cell lung carcinoma

Senecavirus A could be a promising new therapeutic approach for hepatocellular carcinoma

Senecavirus A could be a promising new therapeutic approach for hepatocellular carcinoma

Association of HLA-G*0104N allele with increased risk of recurrent pregnancy loss in Kashmiri population

Association of HLA-G*0104N allele with increased risk of recurrent pregnancy loss in Kashmiri population

New light-based detection method improves screening for food contaminants

New light-based detection method improves screening for food contaminants

New MDMA variants could be promising alternatives for safe psychotherapeutic applications

New MDMA variants could be promising alternatives for safe psychotherapeutic applications

Genetic variation in people of African ancestry linked to increased risk of diabetes complications

Genetic variation in people of African ancestry linked to increased risk of diabetes complications

Novel genetic predisposition to being overweight or obese identified

Novel genetic predisposition to being overweight or obese identified

Open-source platform enables high-definition spatial transcriptomics

Open-source platform enables high-definition spatial transcriptomics

MicroRNAs shed light on aggressive youthful type 2 diabetes

MicroRNAs shed light on aggressive youthful type 2 diabetes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.